류마티스 관절염의 진단과 치료

배상철,Bae, Sang-Cheol 한국건강관리협회 2002 건강소식 Vol.26 No.4

기업의 특허상호실시계약(Cross License Agreement)에 관한 법적 연구

배상철 한국지식재산학회 2008 産業財産權 Vol.- No.27

At a recent, hundreds of news on a cross license agreement signed between firms has been reported. The cross license which the cross grants are symmetrical, against a normal license agreement is one of technology transfers through technical cooperation. The number of the cross licensing deals has been increasing in technical advanced countries, in particular USA, EU, JAPAN. Fousing electronics industry, competitors have entered into cross licenses to eliminate the possibility of patent infringement litigation between them. On the other hand, the domestic manufacturers have been using the cross license as a strategic tool for a technical cooperation. In spite of the growing importance of the cross license agreement, Korea’s legislative system is weak in dealing with this issue. The cross license agreement is basically similar to a normal license agreement except for some particularities; a license exchange, a technical cooperation method between the same kind of firms, etc. From this point of view, the study corresponding to the growing issues on cross license deals is to focus on the background of a expansive trend, the legal nature, the object and terms of licensing. Considering the parties keep contract of the cross license agreement or the details under wraps, there are limitations to data accessibility to obtain the written contracts.

An Impact of Corporate Venture Capital Investment on the Value of Global Fintech Startups

배상철 한국혁신학회 2022 한국혁신학회지 Vol.17 No.1

Global venture capital investment continues to increase and investment in fintech startups is also showing a remarkable increase. Fintech startups are leading digital innovation in the financial industry aimed at address- ing pain points, which exist in the ecosystem of traditional financial institutions. In particular, the startup companies are improving conveniences such as payment, remittance, and asset management services. Meanwhile, robo-advisor companies are expanding their influence in capital markets by outperforming bench- marks with a low commission system. However, research on factor analysis that contribute to value increase in the growth process of fintech startups remains at a conceptual level. This is because global fintech industry growth has been rapid in recent few years, while growth of fintech industry in Korea has been relatively slow, due to regulations and systems that hinder the growth of related companies. Hence, it is difficult to obtain related research data. The purpose of this study is to empirically analyze whether Corporate Venture Capital (CVC), which aims at both financial performance and strategic collaboration, has affected the increase in the value of global fintech startups. There have been various studies on the impact of CVC investment on technology-based (or high-tech) startups, but this study analyzed the effect of CVC investment on fintech startups that have not been studied much before. To this end, global fintech dataset from 2000 to 2020 was used to analyze the impact of variables such as CVC investment, the company's business history, the founder's final school level, and the type of service provided on the corporate value of fintech startups. As a result of the analysis, the conclusion is that CVC investment had a significant effect on the value increase of fintech startups. Especially, in the growth stage of fintech, CVC investment in the late stage was the most effective, and by service type, CVC investment in the asset management segment was the most significant. This study provides an opportunity to review the importance of policies to vitalize CVC investment, along with the meaning of theoretical proof of the role of CVC investment in the growth of fintech companies.

만성 흉수로 내원하여 황색 조갑 증후군으로 진단된 1예

배상철,이성순,정훈,박혜경,신정아 대한내과학회 2011 대한내과학회 추계학술대회 Vol.2011 No.1

Introduction: 황색 조갑 증후군은 특징적 조갑 변화, 원발성 림프 부종과 함께 흉수, 만성 기관지염, 기관지 확장증, 부비동염 등의 호흡기질환이 동반하는 것으로 알려진 질환이다. 현재 국내에 4차례 보고되었고 이 중 1예에서 림프관 조영술에서 이상소견이 관찰되었음을 보고했다. 저자들은 호흡곤란으로 내원한 70세 여자에게서 황색의 조갑 변화 및 만성 흉수, 림프 부종의 임상소견에도 불구하고 림프관 조영술에서 정상소견을 보인 황색 조갑 증후군을 보고하고자 한다. Case: 환자는 70세 여자로 1995년 결핵 진단 받은 이후 완치 판정된 분으로 2002년 시작된 호흡곤란, 발열, 만성 흉수로 반복적인 흉수천자를 받은 분이다. 이외에 2007년 전신성 홍반 루프스로 경과관찰 중이며 2006년부터 상악 부비동염으로 1년에 평균 2-3차례 치료를 받았다. 2009년 이뇨제 복용에도 불구하고 반복적인 양 다리의 부종으로 림프관 조영술을시행하였으나 정상 소견을 나타내었으며 현재 경과관찰 중이었다. 2011년 5월 외래에서 기침과 호흡곤란을 주소로 입원하였으며 당시 양손발톱의 황색의 변화를 보이고 있었고 발목의 부종이 관찰되었다. 검사실 소견상 요화학 검사에서 2+의 단백뇨가 관찰되었으며 가슴 촬영술에서 좌측 흉수가 발견되었다. 흉수는 천자를 통하여 림프구성(90%) 삼출성 흉수였으며 천자 및 배액술을 시행하였다. 이후 루프이뇨제경구투여를 통한 흉수 및 부종조절 후에 외래 경과관찰 중이다. Conclusion: 황색 조갑 증후군은 림프부종 및 흉수 등이 동반되므로 림프순환의 이상이 있을 것으로 추측되고 있으며 국내의 증례 중 1예에서 림프관 조영술을 통하여 림프 순환의 장애가 동반되었음을 보고한 바가 있으나 림프 순환 장애가 없음에도 황색 조갑 증후군을 나타내는 예는 국내에 보고된 적이 없기에 이에 대한 증례를 추가하고자 한다.

류마티스 관절염의 역학 및 원인

배상철 대한의사협회 2010 대한의사협회지 Vol.53 No.10

Rheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects the joints. The prevalence and incidence of RA vary among different populations. In the majority of epidemiologic studies carried out in North America, the prevalence of RA is estimated to be 0.5-1.1%, and the incidence, 20 to 50 cases per 100,000 population. The prevalence of RA in Korea has been reported to be 1.1-2.1%. Some studies have shown a decline in both the prevalence and incidence of RA after the 1960s, but more recent trends in RA incidence are not as wellknown. RA is considered to be a multifactorial disease that results from interactions among genetic and environmental factors. The genetic contribution to RA pathogenesis has been estimated to be approximately 60%, and the HLA region has consistently shown the strongest genetic association with RA. Moreover, recent genetic studies of RA have identified a number of novel RA susceptibility genes, such as PADI4, PTPN22, STAT4, and TRAF1-C5. Though several genes, including HLA-DRB1 and STAT4, have been confirmed to be shared susceptibility genes among Asians and Caucasians, some of the susceptibility genes, such as PADI4 and PTPN22, are restricted to specific ethnic populations, revealing the presence of genetic heterogeneity in RA. Among environmental factors, smoking has by far the strongest association with RA in both the development of the disease and worse outcomes. A major gene-environment interaction between the HLA shared epitope and smoking is one of the most important findings from recent etiologic studies of RA. Further studies of RA susceptible genes and environmental risk factors will bring us closer to understanding the pathogenesis of RA.

형태모방(데드카피) 방지제도에 관한 연구

배상철 한국발명진흥회 2003 發明特許 Vol.28 No.8

약자의 관점에서 본 민법 제104조의 통용상 문제점-특히 불공정한 법률행위의 성립요건인 「포리자의 이용 」을 중심으로-

배상철 한국비교사법학회 2000 비교사법 Vol.7 No.2

미등록의장의 모방(dead copy) 방지제도에 관한 소고 : 일본 부정경쟁방지법상 상품형태모방금지조항을 중심으로

배상철 한국지식재산학회 2003 産業財産權 Vol.- No.14

It is growing trend that there has been no adequate function against the counterfeiting of industrial designs with short life cycle, which results in the increase of the damages of dead copy. This trend is ascertained to the long pendency from application to registration of industrial designs under the current law system and to the characteristic of industrial designs being easily copied. The Korean Intellectual Property Office(KIPO) has recently put an notice for the revised bill which would newly regulate the sale of counterfeited goods of unregistered designs from others as an unfair competition act under the certain requirements. It is envisaged that this provision is basically modeled after the newly stipulated provision in Japan, namely the anti- counterfeiting provision of dead copy in the shape of goods (Article 2(1)(3)), under the Unfair Competition Provention Act revised in 1993. This anti-counterfeiting provision of dead copy in the shape of goods is proposed with an objective to be effectively used for the protection of short life-cycle designs against counterfeiting. The provision has two-tier protection system, one of which is the unregistered protection through the Unfair Competition Prevention Act, and the other is the registered protection with requirements under the Design Act. It is understood that the provision has the same legislative purpose as the EU Design Regulation or the Copyright, Design and Patent Act 1988(CDPA) of UK. Therefore, it is meaningful to review and analyze the anti-counterfeiting provision of dead copy in the shape of goods under the Unfair Competition Prevention Act in Japan. And this study focuses on the application requirements of this provision to the under the Unfair Competition Prevention Act in Japan.

Perdipine의 강압효과에 관한 임상적 관찰

배상철,차호진,김광익,림헌길,이방헌,이정균 대한순환기학회 1985 Korean Circulation Journal Vol.15 No.3

Propofol을 이용한 정맥마취시 Nicardipine의 정주가 기관내 삽관시 혈역학적 변화에 미치는 영향

배상철 순천향의학연구소 2006 Journal of Soonchunhyang Medical Science Vol.12 No.2

Background: Laryngoscopy and tracheal intubation often provoke an undesirable increase in blood pressure and heart rate. Many approaches have been tried to attenuate these hemodynamic responses. This study was designed to determine the optimal dose of nicardipine(N) for maintenace of hemodynamic stability during intravenous with propofol. Methods: Sixty ASA physical class 1 patients were randomly divided four groups of fifteen patients. Saline (control), N 0.5mg(N0.5), N 1mg(N1), and N 1.5mg(N1.5). Tracheal intubation under direct laryngoscopy was perfomed. After intravenous thiopental 5mg/kg, vecuronium 0.12mg/kg, 0.5, 1 and 1.5mg of nicardipine was given intravenously followed by mask ventilation of three minutes with propofol, nitrous oxide and oxygen. Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure(MAP) and heart rate(HR) were recorded at the resting state, preintubation, immediately after intubation, 1, 2, 3, 4 and 6 minutes following intubation. Results: After tracheal intubation, the increase of systolic blood pressure was suppressed significantly by nicardipine 1 and 1.5mg group compared with the control group. But the increase of heart rate was the greatest in the nicardipine 1.5mg group. Condusions: We suggest that the appropriate dose of nicardipine during induction with propofol for attenuation of pressor response to laryngoscopy and intubation in healthy patients is 1mg.